KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Equity Income (2016 - 2025)

Evolent Health has reported Equity Income over the past 12 years, most recently at $65000.0 for Q4 2025.

  • Quarterly results put Equity Income at $65000.0 for Q4 2025, down 59.12% from a year ago — trailing twelve months through Dec 2025 was $446000.0 (up 112.96% YoY), and the annual figure for FY2025 was $365000.0, up 110.61%.
  • Equity Income for Q4 2025 was $65000.0 at Evolent Health, down from $200000.0 in the prior quarter.
  • Over the last five years, Equity Income for EVH hit a ceiling of $7.8 million in Q1 2021 and a floor of -$2.2 million in Q3 2024.
  • Median Equity Income over the past 5 years was $250000.0 (2023), compared with a mean of $809050.0.
  • Biggest five-year swings in Equity Income: surged 2122.22% in 2022 and later crashed 950.0% in 2024.
  • Evolent Health's Equity Income stood at $454000.0 in 2021, then skyrocketed by 45.37% to $660000.0 in 2022, then tumbled by 95.76% to $28000.0 in 2023, then surged by 467.86% to $159000.0 in 2024, then crashed by 59.12% to $65000.0 in 2025.
  • The last three reported values for Equity Income were $65000.0 (Q4 2025), $200000.0 (Q3 2025), and $200000.0 (Q2 2025) per Business Quant data.